Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Astellas Pharma Nuf
NUF
Active
Org 968090364
C. J. Hambros Plass 2, 0164
Oslo
Activities of agents involved in the wholesale of other particular products
·
NACE 4618
Est. 1995 · 31 years old
5 employees
www.astellas.com
Monitor
Share
Norway
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
Astellas Pharma Nuf
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MA
Mark Andree Dekker
Chief Executive Officer
Chief Executive Officer
2025
Former (4)
MA
Morten Auscher
Chief Executive Officer
Chief Executive Officer
2025 – 2025
KH
Karl Håkan Lennart Widen
Chief Executive Officer
Chief Executive Officer
2022 – 2025
PW
Paul Waaler
Chief Executive Officer
Chief Executive Officer
2015 – 2021
AS
Anniken Strid
Contact Person
Contact Person
2021 – 2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Astellas Pharma Nuf
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network